You are here » Home » Companies » Company Overview » Kilitch Drugs (India) Ltd

Kilitch Drugs (India) Ltd.

BSE: 524500 Sector: Health care
NSE: KILITCH ISIN Code: INE729D01010
BSE LIVE 19:40 | 19 Oct 71.45 0.95
(1.35%)
OPEN

73.00

HIGH

73.50

LOW

70.05

NSE 19:31 | 19 Oct 73.60 2.65
(3.74%)
OPEN

71.00

HIGH

74.00

LOW

71.00

OPEN 73.00
PREVIOUS CLOSE 70.50
VOLUME 1330
52-Week high 75.75
52-Week low 32.85
P/E
Mkt Cap.(Rs cr) 95
Buy Price 71.45
Buy Qty 429.00
Sell Price 0.00
Sell Qty 0.00
OPEN 73.00
CLOSE 70.50
VOLUME 1330
52-Week high 75.75
52-Week low 32.85
P/E
Mkt Cap.(Rs cr) 95
Buy Price 71.45
Buy Qty 429.00
Sell Price 0.00
Sell Qty 0.00

Kilitch Drugs (India) Ltd. (KILITCH) - Chairman Speech

Company chairman speech

Dear Valued Shareholders

On behalf of the Board of Directors

I extend a warm Welcome to all of you to the 24th Annual General Meeting of ourcompany.

During the course of the year exports touched the highest levels with businessactivities being opened up in new markets across the globe.

During the year 2015-16 we initiated a number of strategically guided and decisivesteps which shall help us in establishing as market leader in years to come.

With the addition of more products in effervescence range the company has now become amarket leader in the said range in the Francophone Countries.

New Marketing techniques coupled with promotional campaigns have made way for ourproducts in those markets.

I believe that we have opened up various new horizons across all our lines of business.

I intend to reassure our commitment to the stakeholders and we shall always thrive forthe same.

Mukund P. Mehta

Managing Director